Patent Foramen Ovale Clinical Trial
Official title:
Residual Shunt After Patent Foramen Ovale Device Closure in Patients With Cryptogenic Stroke: Serial Bubble Contrast Transesophageal Echocardiography Data
Among consecutive 47 cryptogenic stroke patients who underwent PFO closure, a serial follow-up bubble contrast TEE at 3 and 9 months after the index procedure was completed in 38 patients (81%, 46±10 years, 19 men). To evaluate the efficacy of PFO closure, the incidence of any- and significant residual shunt (≥moderate) was assessed.
The current investigation analyzed the date from the Gachon University Gil Medical Center PFO registry. Between March 2014 to February 2017, all consecutive 47 patients with ischemic stroke and PFO documented by bubble contrast with no other identifiable cause of the ischemic event, such as, carotid or intracranial artery stenosis, atrial fibrillation, and thrombus, or atheromatous plaque at the aortic arch (i.e. CS), were analyzed. PFO closure was determined according to the heart-brain team's discretion (the team consisted of an interventional cardiologist, an echocardiographer cardiologist, a neurologist, and a radiologist) based on clinical data, echocardiographic findings, and patients' preference. The Gore® Septal Occluder (WL Gore & Associates, Inc., Newark, DE, USA) (n=19) and the Amplatzer® PFO occluder (St. Jude Medical, Inc. St.Paul, MN, USA) (n=19) and were used. The Occlutec® PFO occluder was used in one patient who were excluded from the analysis. The Institutional Review Board of Gachon University Gil Medical Center approved this study and all patients provided written informed consent prior to enrollment. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT06192173 -
Patent Foramen Ovale Closure in Migraine
|
||
| Recruiting |
NCT04610463 -
Evaluation of the Severity of Right to Left Shunt in PFO Patients After Systemic Embolism
|
N/A | |
| Completed |
NCT02882815 -
Post Market Clinical Follow-up Study of IrisFITTM PFO (Patent Foramen Ovale) Occluder
|
N/A | |
| Completed |
NCT04604015 -
RoBotic TCD Ultrasound BubbLe Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt
|
N/A | |
| Active, not recruiting |
NCT04950192 -
Philips Intracardiac Echocardiography (ICE) Clinical Registry
|
||
| Not yet recruiting |
NCT04549272 -
Assessment of Early Vascular Damage With Advanced Neuroimaging in Patient With Patent Foramen Ovale
|
||
| Completed |
NCT02621528 -
Lifetech CeraFlex™ Post-Market Surveillance Study
|
N/A | |
| Terminated |
NCT01018355 -
The Effect of Device Closure of Patent Foramen Ovale in Elderly Patients With Crytogenic Stoke/TCI
|
N/A | |
| Completed |
NCT00831259 -
Risk of Stroke in Pulmonary Embolism With a Patent Foramen Ovale (PFO)
|
N/A | |
| Not yet recruiting |
NCT05360771 -
Study on the Safety and Effectiveness of the SnowyTM PFO Closure System
|
N/A | |
| Recruiting |
NCT05546320 -
Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale
|
Phase 4 | |
| Recruiting |
NCT05561660 -
COMParison of the EffecT of dEvice Closure in Alleviating Migraine With PFO (COMPETE-2)
|
Phase 4 | |
| Completed |
NCT03904277 -
Does Patent Foramen Ovale Size Matter in Men and Women
|
||
| Recruiting |
NCT06120270 -
CeraFlex PFO Closure System PMCF Study
|
||
| Terminated |
NCT01773252 -
Right to Left Cardiac Shunt Detection
|
Phase 3 | |
| Completed |
NCT01216423 -
Pulmonary Embolism and Stroke in Patient With Patent Foramen Ovale
|
N/A | |
| Completed |
NCT03377465 -
Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis
|
N/A | |
| Active, not recruiting |
NCT04738071 -
International Multicenter Patent foRamen OVale & strokE (IMPROVE) Registry
|
||
| Not yet recruiting |
NCT06344494 -
Cardiac Interventional ICE Imaging Trial
|
N/A | |
| Withdrawn |
NCT02378623 -
Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical Emboli
|
Phase 2 |